Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Plos Genetics|November 11, 2021
Positive correlation between transcriptomic stemness and PI3K/AKT/mTOR signaling scores in breast cancer, and a counterintuitive relationship with PIK3CA genotypeRalitsa R Madsen, Emily C Erickson, Oscar M Rueda, et al.
Scientific Reports|May 24, 2024
Development and validation of a reliable DNA copy-number-based machine learning algorithm (CopyClust) for breast cancer integrative cluster classificationCameron C Young, Katherine Eason, Raquel Manzano Garcia, et al.
Scientific Reports|July 11, 2026
Breast cancer genomic subtype-specific copy number alterations in metastasesKatherine Eason, Christopher Boursnell, Raquel Manzano, et al.
Plos One|December 19, 2013
A prognostic gene signature for metastasis-free survival of triple negative breast cancer patientsUnjin Lee, Casey Frankenberger, Jieun Yun, et al.
Molecular Oncology|June 3, 2020
Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated featuresGal Benor, Garold Fuks, Suet-Feung Chin, et al.
Breast Cancer Research : BCR|February 13, 2021
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1Silvana Mouron, Luis Manso, Eduardo Caleiras, et al.
Cellular and Molecular Life Sciences : CMLS|September 28, 2019
Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylationBethany Mason, Susanne Flach, Felipe R Teixeira, et al.
Cell Reports|December 22, 2015
Context-Specific Effects of TGF-β/SMAD3 in Cancer Are Modulated by the EpigenomeAna Tufegdzic Vidakovic, Oscar M Rueda, Stephin J Vervoort, et al.
BMC Genomics|January 7, 2018
Computational approach to discriminate human and mouse sequences in patient-derived tumour xenograftsMaurizio Callari, Ankita Sati Batra, Rajbir Nath Batra, et al.
Cell Research|May 26, 2018
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer modelsZheng Xue, Daniel J Vis, Alejandra Bruna, et al.
Pageof 10